Literature DB >> 11698304

Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain.

G B Ferrara1, A Bacigalupo, T Lamparelli, E Lanino, L Delfino, A Morabito, A M Parodi, C Pera, S Pozzi, M P Sormani, P Bruzzi, D Bordo, M Bolognesi, G Bandini, A Bontadini, M Barbanti, G Frumento.   

Abstract

The hypothesis was tested that amino acid substitutions in specific positions within human leukocyte antigen class I heavy chain would have different impacts on transplant-related mortality (TRM) in patients receiving transplanted bone marrow from unrelated donors. One hundred patients and their unrelated donors were typed by sequence-based typing for the human leukocyte antigen (HLA)-A, -B, and -C loci. All pairs were matched for DRB1, DRB3, DRB4, DRB5, DQA1, and DQB1 loci. Forty pairs were also matched at class I, and 60 pairs had one or more mismatches at class I loci. It was found that substitutions at positions 116 and 114 of class I heavy chain significantly increased the risk for TRM in univariate and bivariate Cox analyses. Conversely, no association between number of multiple mismatches or number of amino acid substitutions and TRM was seen when positions 116 and 114 were adjusted for. Variables predictive of TRM in multivariate Cox analysis were number of cells infused, diagnosis (chronic myeloid leukemia [CML] or non-CML), and amino acid substitution at position 116 or 152. The only variable predictive of severe acute graft-versus-host disease (GVHD) in multivariate Cox analysis was substitution at position 116. Actuarial risk for acute GVHD grade III-IV, TRM, and relapse in pairs with substitutions at position 116 (n = 37) compared to other pairs (n = 63) was, respectively, 36% versus 14% (P =.01), 59% versus 28% (P =.001), and 25% versus 31% (P =.4). In conclusion these data suggest that substitutions at position 116 of class I heavy chain increase the risk for acute GVHD and TRM in patients who receive transplanted bone marrow from unrelated donors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698304     DOI: 10.1182/blood.v98.10.3150

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

Review 1.  Allogeneic hematopoietic cell transplantation: the state of the art.

Authors:  Boglarka Gyurkocza; Andrew Rezvani; Rainer F Storb
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

2.  Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

Authors:  Joseph Pidala; Tao Wang; Michael Haagenson; Stephen R Spellman; Medhat Askar; Minoo Battiwalla; Lee Ann Baxter-Lowe; Menachem Bitan; Marcelo Fernandez-Viña; Manish Gandhi; Ann A Jakubowski; Martin Maiers; Susana R Marino; Steven G E Marsh; Machteld Oudshoorn; Jeanne Palmer; Vinod K Prasad; Vijay Reddy; Olle Ringden; Wael Saber; Stella Santarone; Kirk R Schultz; Michelle Setterholm; Elizabeth Trachtenberg; E Victoria Turner; Ann E Woolfrey; Stephanie J Lee; Claudio Anasetti
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

Review 3.  In celebration of Ruggero Ceppellini: HLA in transplantation.

Authors:  E W Petersdorf
Journal:  HLA       Date:  2017-02       Impact factor: 4.513

4.  Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease.

Authors:  Sharon R Hymes; Amin M Alousi; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2012-04       Impact factor: 11.527

5.  Polymorphism, natural selection, and structural modeling of class Ia MHC in the African clawed frog (Xenopus laevis).

Authors:  D H Bos; B Waldman
Journal:  Immunogenetics       Date:  2006-04-28       Impact factor: 2.846

Review 6.  Genetics of graft-versus-host disease: the major histocompatibility complex.

Authors:  Effie W Petersdorf
Journal:  Blood Rev       Date:  2012-11-20       Impact factor: 8.250

7.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

8.  Evaluation of DRB1 high resolution typing by a new SSO-based Luminex method.

Authors:  Manuela Testi; Sandra Iannelli; Giuseppe Testa; Maria Troiano; Simonetta Capelli; Fiorenza Fruet; Giorgio Federici; Andrea Bontadini; Marco Andreani
Journal:  Mol Biol Rep       Date:  2011-03-22       Impact factor: 2.316

Review 9.  Optimal HLA matching in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf
Journal:  Curr Opin Immunol       Date:  2008-08-08       Impact factor: 7.486

Review 10.  New advances in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; John A Hansen
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.